By Sterling Medical Staff
According to James I. Ausman, M.D., Ph.D., and Ronald P. Pawl, M.D., biological advances and technological innovations will change neurosurgical practices. Targeted molecular therapies are leading to better therapies in cancer and other treatments. Technological advances in neuroimaging will lead to better visualization and aid computer assisted surgery, improving neurosurgical outcomes.
Combining all of the recent advances and vast amounts of supplemental education needed for neurosurgeons will create super-specializations and the need for careful collaboration with other medical specializations, sciences, and professions.
Neurosurgeons will need to perform research into areas such as cell implantation, “genetic, behavioral, and immunological phenomena involved to achieve success as did transplant surgeons 25 years ago…” according to Dr. Ausman and Dr. Pawl. Otherwise, physicians in more cutting edge specialties will lead the way.
James I. Ausman, M.D., Ph.D., and Ronald P. Pawl, M.D., Department of Neurosurgery, University of Illinois at Chicago, Illinois